A detailed history of State Street Corp transactions in Tela Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 65,483 shares of TELA stock, worth $191,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,483
Previous 107,435 39.05%
Holding current value
$191,210
Previous $504,000 67.26%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.32 - $5.04 $97,328 - $211,438
-41,952 Reduced 39.05%
65,483 $165,000
Q2 2024

Aug 14, 2024

SELL
$4.39 - $6.36 $1.18 Million - $1.7 Million
-267,933 Reduced 71.38%
107,435 $504,000
Q1 2024

May 15, 2024

BUY
$5.3 - $7.61 $290,572 - $417,218
54,825 Added 17.1%
375,368 $2.13 Million
Q4 2023

Feb 14, 2024

BUY
$4.5 - $7.51 $187,519 - $312,949
41,671 Added 14.94%
320,543 $2.12 Million
Q3 2023

Nov 14, 2023

SELL
$7.85 - $10.68 $22,003 - $29,936
-2,803 Reduced 1.0%
278,872 $2.23 Million
Q2 2023

Aug 14, 2023

BUY
$9.23 - $11.23 $2.32 Million - $2.82 Million
251,210 Added 824.59%
281,675 $2.85 Million
Q4 2022

Feb 14, 2023

BUY
$6.5 - $11.5 $28,600 - $50,600
4,400 Added 16.88%
30,465 $350,000
Q1 2022

May 16, 2022

BUY
$11.35 - $13.7 $24,595 - $29,687
2,167 Added 9.07%
26,065 $303,000
Q3 2021

Nov 15, 2021

BUY
$12.2 - $15.93 $62,220 - $81,243
5,100 Added 27.13%
23,898 $326,000
Q2 2021

Aug 16, 2021

SELL
$11.7 - $16.11 $994,476 - $1.37 Million
-84,998 Reduced 81.89%
18,798 $303,000
Q1 2021

May 17, 2021

BUY
$12.84 - $17.26 $109,576 - $147,296
8,534 Added 8.96%
103,796 $1.55 Million
Q4 2020

Feb 16, 2021

BUY
$14.61 - $17.59 $433,215 - $521,578
29,652 Added 45.19%
95,262 $1.43 Million
Q3 2020

Nov 10, 2020

BUY
$11.64 - $16.86 $47,689 - $69,075
4,097 Added 6.66%
65,610 $1.09 Million
Q2 2020

Aug 14, 2020

BUY
$7.75 - $22.61 $476,725 - $1.39 Million
61,513 New
61,513 $797,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $55.9M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.